Topic
Coronavirus Vaccine
COVID-19 vaccine expected to be ready for approval by year end: WSJ
BioNTech SE and Pfizer Inc's COVID-19 vaccine candidate is expected to be ready to seek regulatory approval by the end of 2020, the Wall Street Journal reported on Friday, citing the German biotech ...
UK not to join EU's COVID-19 vaccine scheme
Britain has turned down the chance to join a 2.4 billion euro ($2.7 billion) European Union plan to secure advance purchases of promising COVID-19 vaccines, saying the EU would not allow it any role ...
China leads COVID-19 vaccine race with eight candidates in human trials
China is forging ahead in the race to develop a vaccine to help control the COVID-19 pandemic, with Sinovac Biotech's experimental vaccine set to become the country's second and the world's third to ...
GSK to develop plant-based COVID-19 vaccine
The world's largest vaccine-maker GSK has put its vaccine booster technology to work in a potential new COVID-19 shot, to be developed with a Canadian biopharmaceutical company backed by tobacco ...
China's Sinovac starts Phase III human trials of its COVID-19 vaccine in Brazil
China's Sinovac Biotech is starting Phase III trials of its potential coronavirus vaccine in Brazil, it said on Monday, becoming one of three companies to move into the late stages in the race to ...
India’s second COVID-19 vaccine approved for human trials
Zydus has received approval from Indian regulators to begin human studies for its COVID-19 vaccine contender, the drugmaker said on Friday, as the novel coronavirus infections continue to surge in ...
Brazil to test China's potential COVID-19 vaccine in six states
A potential coronavirus vaccine developed by China's Sinovac will be tested in Brazil by 12 research centers in six Brazilian states, the governor of Sao Paulo state, Joao Doria, said on Wednesday, ...
Another COVID-19 vaccine developed by BioNTech & Pfizer shows potential in human trial
A COVID-19 vaccine developed by German biotech firm BioNTech and US pharmaceutical giant Pfizer has shown potential and was found to be well tolerated in early-stage human trials, the companies said ...
US Pharma Inovio's COVID-19 vaccine shows promise in early-stage trial
An experimental coronavirus vaccine developed by Inovio Pharmaceuticals Inc showed promise and was found to be safe in an early-stage human trial, the company said on Tuesday.
Global COVID-19 prevention trial of hydroxychloroquine to resume
The Medicines and Healthcare Products Regulatory Agency (MHRA) took its decision on what is known as the COPCOV trial after hydroxychloroquine was found in another British trial to have no benefit as ...
Load More